Inflammatory Astrocytes in ALS <table class="infobox infobox-cell">
Introduction Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic "A1" profile that promotes inflammation and fails to provide necessary support to motor neurons[@ilieva2019].
...
Inflammatory Astrocytes in ALS <table class="infobox infobox-cell">
Introduction Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic "A1" profile that promotes inflammation and fails to provide necessary support to motor neurons[@ilieva2019].
The recognition of inflammatory astrocytes as key drivers of ALS pathogenesis has fundamentally changed our understanding of disease mechanisms. Rather than being passive responders to motor neuron injury, these astrocytes actively contribute to neurodegeneration through the secretion of toxic factors and loss of protective functions.
Overview Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic profile that promotes inflammation and fails to provide necessary support to motor neurons.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0009002)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
[OBO Foundry (CL:0009002)](http://purl.obolibrary.org/obo/CL_0009002)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0009002)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
[OBO Foundry (CL:0009002)](http://purl.obolibrary.org/obo/CL_0009002)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Pathological Features
Morphological Changes
Hypertrophic cell bodies
Increased GFAP expression
Proliferation in spinal cord and motor cortex
Association with motor neuron loss
Molecular Markers The "A1" reactive astrocyte signature includes[@liddelow2017]:
GFAP - Upregulated intermediate filamentC3 - Complement component C3 (A1 marker)Serpina3n - Acute phase proteinLcn2 - Lipocalin-2 (pro-inflammatory)Cxcl10 - Chemokine (IP-10)Mechanisms of Toxicity
Secreted Factors
Complement components - C1q, C3 mediate synapse eliminationPro-inflammatory cytokines - IL-1β, TNF-α, IL-6Chemokines - CXCL10 recruits immune cellsExcitotoxins - Dysregulated glutamate transport
Dysfunctional Support
Reduced glutamate clearance (GLT-1 downregulation)
Impaired potassium buffering
Decreased metabolic support
Reduced neurotrophic factor secretion
Excitotoxicity The primary mechanism of astrocyte-mediated toxicity in ALS:
GLT-1 (EAAT2) downregulation : Reduced glutamate uptakeElevated extracellular glutamate : Motor neuron excitotoxicityAMPA/kainate receptor overactivation : Calcium influxCell death : Programmed necrosis and apoptosisDisease Context
Sporadic ALS
Most common form (~90-95% of cases)
Reactive astrocytes cluster around remaining motor neurons
Variable A1/A2 polarization
Variable inflammatory profiles across patients
Familial ALS
SOD1 Mutations
Strong astrocyte involvement in pathogenesis
Mutant SOD1 secreted by astrocytes
Non-cell autonomous toxicity to motor neurons
Well-characterized mouse models
C9orf72 Expansion
DPR (dipeptide repeat) toxicity in astrocytes
RNA foci formation
Stress granule accumulation
Impaired proteostasis
FUS Mutations
RNA metabolism disruption
Mislocalized FUS protein
Altered transcriptional regulation
TDP-43 Pathology
Ubiquitin dysfunction
Aggregate formation
Autophagy impairment
Astrocyte-Neuron Interaction
Direct Effects
Physical contact with motor neurons
Synapse elimination via complement
Direct毒性因子分泌
Exosome-mediated toxicity
Transfer of mutant proteins
microRNA dysregulation
Disrupted lactate shuttle
Impaired ATP transfer
Mitochondrial dysfunction propagation
Therapeutic Targets
Modulation Strategies
Experimental Approaches
Minocycline : Antibiotic with anti-inflammatory properties (failed in clinical trials)Ceftriaxone : β-lactam antibiotic upregulates GLT-1 (failed phase 3)Gene therapy : AAV-mediated GLT-1 expressioniPSC astrocytes : Patient-derived cells for drug screeningExternal Links
ALS Association : [https://www.als.org/](https://www.als.org/)Allen Cell Type Atlas : [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)PubMed : [https://pubmed.ncbi.nlm.nih.gov/](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature[Cell Types Index](/cell-types) Astrocytes
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Motor Neurons](/cell-types/motor-neurons)
[GFAP](/entities/gfap)
[Excitotoxicity](/mechanisms/excitotoxicity)
--
Background The study of Inflammatory Astrocytes In Als has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Show full description